Cardiovascular disease kills more women than breast, lung and chronic lung disease combined; WHOOP’s data and AI initiatives aim to provide gender-specific insights, requiring systematic integration.
Advocate Health will spend $1.24 billion on its workforce in 2027, raising the minimum wage to $20 and adding $390 million in new benefits.
The U.S. FDA’s clearance of Sunharbo (asundexian) adds a 26% risk-reduction option for post-stroke patients, but elderly bleeding risk requires careful use.
Siggy debuts a free-intake, AI-augmented mental health platform that blends continuous digital monitoring with clinician-led therapy, backed by $6 million in pre-seed funding.
The FDA’s new Neuroscience Advancement and Innovation Nexus coordinates drugs, biologics and devices, targeting Alzheimer’s prevention with biomarkers and digital tools.
A severely immunocompromised patient in Lyon died after infection with shamonda virus, a cattle-affecting midge-borne pathogen previously seen only in animals.
Walmart teams with General Medicine to turn its Better Care Services into a shoppable health marketplace, adding 900+ products and real-time cost estimates.
UnitedHealthcare expands its generative-AI companion Avery from an initial 6.5 million to 21 million enrollees, reporting 90% query resolution and a data-grounded design that underpins accuracy.
An executive order mandates a new NIH division and White House task force to centralize under-studied women’s conditions, but funding and scope remain unclear.
Longevity clinics are sprouting in major hospitals, promising multitrillion-dollar market upside but raising questions about payer models, regulation and clinical evidence.
The AMA’s new policy mandates that AI systems performing clinical tasks earn authority through evidence, with evolving oversight and clear accountability.
Epic’s new prescription marketplace lets clinicians see insurance and cash prices from multiple pharmacies at the point of care, aiming to cut nonadherence from cost.
Proposed $70k work-authorization fee, visa fraud probes and a four-year cap are already pulling down international PhD applications, forcing labs to rethink hiring.
An enterprise agreement lets the University of Texas System scale Abridge’s clinical AI, boosting clinician adoption and freeing time for bedside care.
The partnership will create “human-first” AI that merges evidence, patient history and Hopkins best practices, reshaping curriculum and bedside decision-making.
An FDA advisory committee says Galleri’s benefits outweigh risks, but reimbursement, workflow and data-privacy hurdles mean health systems must act now to capture value.
A $2.8 billion partnership will slash CenterWell’s cost of capital, fund new sites and give Humana flexible exit rights—shaping senior-care strategy through 2033.
Google’s $180 Fitbit Edge adds AI-driven blood-pressure and insulin-resistance tracking, forcing health systems to rethink data integration, care pathways and payer contracts.
Healthleap’s language-model platform scans EHR notes to surface undiagnosed malnutrition, cutting stays and boosting reimbursements—see the financial upside.
AWS chief says ending nondisclosure deals and $1 billion community spending will restore trust as moratoriums rise across the U.S.
The FDA’s READI-Home program begins, letting five early adopters test home-based diagnostic tools under a new regulatory framework – here’s what leaders must do now.
Messaging-based AI assistants let clinicians automate scheduling, reminders and referrals without extra apps, reshaping how hospitals streamline patient touchpoints.
New federal guidance forces hospitals to separate out-site services from inpatient bills, reducing compliance risk and changing pricing strategy.
Or writehello@arm-age.com